Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ANTITHROMBIN III (HUMAN)
- A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
- Mesoglycan for Acute Hemorrhoidal Disease
- Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
- DOAC in Patients With Child B Liver Cirrhosis
- Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
- A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia
- Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome
- Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
- Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
- Safety and Efficacy of Argatroban Applicated in Anticoagulation of V-V ECMO
- Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
- Antithrombin III in Infectious Disease Caused by COVID-19
- Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
- Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19
- Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial
- Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Dexmedetomidine on Tourniquet Induced -Systemic Effects
- Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke
- Antithrombin III Concentrate After Liver Transplantation
- Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis
- Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
- Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT
- Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring
- A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
- A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
- Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation
- Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
- Impact of LDL-cholesterol Lowering on Platelet Activation
- Antithrombin Supplementation in ECMO
- Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban
- Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients
- Doxazosin and Ramipril in Hypertension
- Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients
- STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
- Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support
- A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population
- Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)
- An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B
- Atenativ Effect on Uterine Blood Flow and Preeclampsia
- TEG Anticoagulation Monitoring During ECMO
- Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis
- Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis
- Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.
- Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO
- Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation
- Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy
- Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
- Understanding "Heparin Resistance" in Cardiac Surgery
- Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery
- Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac Surgery
- Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo
- An Open-label Study of KW-3357
- Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
- Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
- Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia
- Iloprost Effects on Gas Exchange and Pulmonary Mechanics
- Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery
- Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates
- Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics
- The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
- Heparin for Pregnant Women With Thrombophilia
- Sickle Cell Disease Conditioning for Bone Marrow Transplant
- Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion
- A Study of KW-3357 in Congenital Antithrombin Deficiency
- Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer
- Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
- Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
- Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases
- Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
- Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)
- Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects
- Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression
- Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
- STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction
- The Effect of the Mini-pill on Blood Factors in Women at Increased Risk for Forming Blood Clots
- Birth Control Pill vs Birth Control Patch Study
- Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
- Antithrombotic Regimens and Outcome
- Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
- Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
- Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
- Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy
- Tranexamic Acid, Hemorrhage and Transfusions After Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery.
- Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
- Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
- Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)
- The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress
Clinical trials list
click for details